Adherence During COVID-19: The Role of Aging and Socio-economics Status in Shaping Drug Utilization

Overview

Journal J Econ Behav Organ

Date 2022 Oct 21

PMID 36268162

Authors

Cinzia Di Novi

Lucia Leporatti

Rosella Levaggi

Marcello Montefiori

Affiliations

Soon will be listed here.

Abstract

Our study investigates the potential impact that COVID-19 and lockdown restrictions may have had on drug utilization and the role of patient age and education in reshaping it. We focused on patients affected by diabetes mellitus, who are likely to suffer a higher degree of morbidity and mortality due to COVID-19. We used a bi-monthly administrative panel dataset from January 2019 to December 2020 from Liguria (Italy), one of the regions with the highest number of individuals over the age of 65 in Europe. The results demonstrated that, after the initial shock, when patients tried to increase their personal stock of drugs to overcome the risk of possible additional barriers generated by the coronavirus, the hoarding effect almost disappeared. Adherence has drastically reduced during the COVID-19 pandemic and has never reached pre-COVID levels again. Older and poorly educated patients seem to have suffered more from the restrictions imposed by the lockdown and fear of contagion and they may be the ideal target group when considering possible policy interventions to improve adherence.

Citing Articles

Tracking continuous positive airway pressure adherence in obstructive sleep apnea patients before, during, and after the COVID-19 lockdown.

BaHammam A, Alhuqayl F, Alzaid I, Alzammam Z, Alhuqayl F, Rajeh B Ann Thorac Med. 2025; 20(1):56-61.

PMID: 39926402 PMC: 11804958. DOI: 10.4103/atm.atm_296_23.

Patients' insights into unused medications during the COVID-19 outbreak: A qualitative study.

Makki M, Shafie A, Awaisu A, Hussain R, Al Hail M, ElMotasim W Explor Res Clin Soc Pharm. 2024; 16:100517.

PMID: 39435401 PMC: 11492333. DOI: 10.1016/j.rcsop.2024.100517.

Impact of COVID-19 Lockdown on Glycemic, Weight, Blood Pressure Control and Medication Adherence in Patients with Type 2 Diabetes.

Sim R, Chong C, Loganadan N, Hussein Z, Adam N, Lee S Patient Prefer Adherence. 2023; 17:2109-2117.

PMID: 37644964 PMC: 10461747. DOI: 10.2147/PPA.S420545.

References

Amstislavski P, Matthews A, Sheffield S, Maroko A, Weedon J . Medication deserts: survey of neighborhood disparities in availability of prescription medications. Int J Health Geogr. 2012; 11:48. PMC: 3517332. DOI: 10.1186/1476-072X-11-48. View

Agh T, van Boven J, Wettermark B, Menditto E, Pinnock H, Tsiligianni I . A Cross-Sectional Survey on Medication Management Practices for Noncommunicable Diseases in Europe During the Second Wave of the COVID-19 Pandemic. Front Pharmacol. 2021; 12:685696. PMC: 8216671. DOI: 10.3389/fphar.2021.685696. View

Barry H, Hughes C . Managing medicines in the time of COVID-19: implications for community-dwelling people with dementia. Int J Clin Pharm. 2020; 43(1):275-279. PMC: 7429133. DOI: 10.1007/s11096-020-01116-y. View

Di Crosta A, Ceccato I, Marchetti D, La Malva P, Maiella R, Cannito L . Psychological factors and consumer behavior during the COVID-19 pandemic. PLoS One. 2021; 16(8):e0256095. PMC: 8366984. DOI: 10.1371/journal.pone.0256095. View

Tang K, Quan H, Rabi D . Measuring medication adherence in patients with incident hypertension: a retrospective cohort study. BMC Health Serv Res. 2017; 17(1):135. PMC: 5307770. DOI: 10.1186/s12913-017-2073-y. View

Pages-Puigdemont N, Tuneu L, Masip M, Valls P, Puig T, Mangues M . Determinants of medication adherence among chronic patients from an urban area: a cross-sectional study. Eur J Public Health. 2018; 29(3):419-424. DOI: 10.1093/eurpub/cky259. View

Horii T, Momo K, Yasu T, Kabeya Y, Atsuda K . Determination of factors affecting medication adherence in type 2 diabetes mellitus patients using a nationwide claim-based database in Japan. PLoS One. 2019; 14(10):e0223431. PMC: 6782087. DOI: 10.1371/journal.pone.0223431. View

Elek P, Biro A, Fadgyas-Freyler P . Income gradient of pharmaceutical panic buying at the outbreak of the COVID-19 pandemic. Health Econ. 2021; 30(9):2312-2320. PMC: 8420393. DOI: 10.1002/hec.4378. View

Di Novi C, Leporatti L, Montefiori M . Older patients and geographic barriers to pharmacy access: When nonadherence translates to an increased use of other components of health care. Health Econ. 2020; 29 Suppl 1:97-109. DOI: 10.1002/hec.4031. View

10.

Wilder M, Kulie P, Jensen C, Levett P, Blanchard J, Dominguez L . The Impact of Social Determinants of Health on Medication Adherence: a Systematic Review and Meta-analysis. J Gen Intern Med. 2021; 36(5):1359-1370. PMC: 8131473. DOI: 10.1007/s11606-020-06447-0. View

11.

Depalo D . Explaining the causal effect of adherence to medication on cholesterol through the marginal patient. Health Econ. 2020; 29 Suppl 1:110-126. DOI: 10.1002/hec.4030. View

12.

Nasri H, Rafieian-Kopaei M . Metformin: Current knowledge. J Res Med Sci. 2014; 19(7):658-64. PMC: 4214027. View

13.

Clement J, Jacobi M, Greenwood B . Patient access to chronic medications during the Covid-19 pandemic: Evidence from a comprehensive dataset of US insurance claims. PLoS One. 2021; 16(4):e0249453. PMC: 8016279. DOI: 10.1371/journal.pone.0249453. View

14.

Kardas P, van Boven J, Pinnock H, Menditto E, Wettermark B, Tsiligianni I . Disparities in European healthcare system approaches to maintaining continuity of medication for non-communicable diseases during the COVID-19 outbreak. Lancet Reg Health Eur. 2021; 4:100099. PMC: 8046426. DOI: 10.1016/j.lanepe.2021.100099. View

15.

Costa-Font J, Rudisill C, Tan S . Brand loyalty, patients and limited generic medicines uptake. Health Policy. 2014; 116(2-3):224-33. DOI: 10.1016/j.healthpol.2014.01.015. View

16.

Song R . Mechanism of Metformin: A Tale of Two Sites. Diabetes Care. 2016; 39(2):187-9. DOI: 10.2337/dci15-0013. View

17.

Atella V, Belotti F, Depalo D . Drug therapy adherence and health outcomes in the presence of physician and patient unobserved heterogeneity. Health Econ. 2017; 26 Suppl 2:106-126. DOI: 10.1002/hec.3570. View

18.

Qato D, Daviglus M, Wilder J, Lee T, Qato D, Lambert B . 'Pharmacy deserts' are prevalent in Chicago's predominantly minority communities, raising medication access concerns. Health Aff (Millwood). 2014; 33(11):1958-65. DOI: 10.1377/hlthaff.2013.1397. View

19.

Yeoh E, Tan S, Lee Y, Tan H, Low Y, Lim S . Impact of COVID-19 and partial lockdown on access to care, self-management and psychological well-being among people with diabetes: A cross-sectional study. Int J Clin Pract. 2021; 75(8):e14319. PMC: 8236933. DOI: 10.1111/ijcp.14319. View

20.

Schernthaner G, Schernthaner G . The right place for metformin today. Diabetes Res Clin Pract. 2019; 159:107946. DOI: 10.1016/j.diabres.2019.107946. View